(HLI) Houlihan Lokey - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4415931009
HLI: Mergers, Acquisitions, Finance, Restructuring, Advisory, Services
Houlihan Lokey is a premier investment banking firm specializing in merger and acquisitions, capital markets, financial restructuring, and valuation services. With a rich history since 1972, theyve carved a niche in restructuring, particularly during economic downturns, earning a strong reputation for their expertise.
Their Corporate Finance segment excels in advising on transactions, from leveraged loans to IPOs, catering to both public and private entities. The Financial Restructuring segment is renowned for its work in recapitalization and deleveraging, offering services like structuring negotiations and viability assessments. The Financial and Valuation Advisory segment provides comprehensive valuations, including intellectual property, and crucial opinions for transactions and disputes.
As a trusted advisor to corporations, financial sponsors, and governments, Houlihan Lokeys broad reach underscores their expertise. With a market cap of over $12 billion, their financials reflect strong investor confidence, highlighted by a P/E ratio of 34.13 and a forward P/E of 24.21. Their services are in high demand across economic cycles, making them a key player in investment banking.
Additional Sources for HLI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HLI Stock Overview
Market Cap in USD | 10,754m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2015-08-13 |
HLI Stock Ratings
Growth 5y | 86.8% |
Fundamental | 61.3% |
Dividend | 68.5% |
Rel. Strength | 5.52 |
Analysts | 2.67/5 |
Fair Price Momentum | 152.87 USD |
Fair Price DCF | 290.02 USD |
HLI Dividends
Dividend Yield 12m | 1.50% |
Yield on Cost 5y | 4.37% |
Annual Growth 5y | 12.04% |
Payout Consistency | 100.0% |
HLI Growth Ratios
Growth Correlation 3m | -69.8% |
Growth Correlation 12m | 81.7% |
Growth Correlation 5y | 91.6% |
CAGR 5y | 22.86% |
CAGR/Max DD 5y | 0.63 |
Sharpe Ratio 12m | 1.55 |
Alpha | 13.68 |
Beta | 0.732 |
Volatility | 29.41% |
Current Volume | 779.7k |
Average Volume 20d | 456.9k |
As of April 06, 2025, the stock is trading at USD 146.39 with a total of 779,749 shares traded.
Over the past week, the price has changed by -7.41%, over one month by -9.21%, over three months by -15.22% and over the past year by +15.02%.
Yes, based on ValueRay Fundamental Analyses, Houlihan Lokey (NYSE:HLI) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.26 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HLI as of April 2025 is 152.87. This means that HLI is currently overvalued and has a potential downside of 4.43%.
Houlihan Lokey has received a consensus analysts rating of 2.67. Therefor, it is recommend to hold HLI.
- Strong Buy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 3
According to ValueRays Forecast Model, HLI Houlihan Lokey will be worth about 168.4 in April 2026. The stock is currently trading at 146.39. This means that the stock has a potential upside of +15.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 188 | 28.4% |
Analysts Target Price | 181.1 | 23.7% |
ValueRay Target Price | 168.4 | 15.1% |